基于骨髓微环境介导PI3K/Akt通路研究复方君子汤治疗急性髓系白血病机制OA
Exploring the Mechanism of Fufang Junzi Decoction in the Treatment of Acute Leukemia was Studied Based on the Bone Marrow Microenvironment Mediated PI3K/Akt Signaling Pathway
目的:探究复方君子汤(FFJZ)通过骨髓微环境介导PI3K/Akt信号通路治疗急性髓系白血病(AML)的作用机制.方法:构建 AML细胞(K562/VCR)与人骨髓基质细胞共培养模型,模拟白血病细胞在骨髓微环境中的生存状态,设置对照组、FFJZ组及联合组(FFJZ+阿糖胞苷).通过显微镜观察细胞形态变化,CCK-8法检测细胞存活率与增殖抑制率,流式细胞术分析凋亡率,Western blot验证PI3K、Akt、eIF4B磷酸化水平及Bcl-2、Bax蛋白表达.实验分单独培养与黏附共培养两种条件.结果:①细胞形态:与对照组比较,FFJZ组细胞数目明显减少(50%),部分细胞体积固缩,形态不规则;联合组细胞数量减少最严重(75%),大部分细胞体积缩小,有大量细胞碎片游离于细胞培养液中.②存活与增殖抑制:FFJZ组及联合组均显著降低 K562/VCR细胞存活率,且联合组效果优于单药组(F=6.808,P<0.001),共培养体系下各组细胞存活率高于单独培养组(F=106.968,P<0.001),增殖抑制率低于单独培养组(F=103.228,P<0.001).③凋亡调控:A组中,与对照组(8.15%)比较,FFJZ组(20.72%)和联合组(38.95%)细胞凋亡均显著升高,以联合组尤为明显(P<0.05);B组中,各组别细胞凋亡结果与 A组趋势一致,并且各组别细胞凋亡低于 A组(F=32.67,P<0.05).④信号通路调控:共培养细胞中,FFJZ组、联合组PI3K、Akt、eIF4B磷酸化水平及Bcl-2蛋白表达下调(P<0.05),Bax蛋白上调(P<0.05).结论:FFJZ联合阿糖胞苷对 AML细胞具有增强促进细胞凋亡作用,其机制可能与骨髓微环境介导PI3K/Akt通路有关,FFJZ抑制PI3K/Akt通路激活,下调eIF4B磷酸化,上调促凋亡基因BAX,下调抗凋亡基因BCL-2的表达水平,加快白血病细胞凋亡,从而达到治疗 AML的作用.这可为 AML靶向治疗提供参考.
Objective:To explore the mechanism of action of the compound Fufang Junzi Decoction(FFJZ)in treating acute myeloid leukemia(AML)through the bone marrow microenvironment mediated PI3K/Akt signaling pathway.Methods:A co-culture model of AML cells(K562/VCR)and human bone marrow stromal cells was established to simulate the survival state of leukemia cells in the bone marrow microenvironment.The control group,FFJZ group,and combination group(FFJZ+cytarabine)were set up.Cell morphology changes were observed under a microscope,cell survival rate and proliferation inhibition rate were detected by CCK-8 assay,apoptosis rate was analyzed by flow cytom-etry,and the phosphorylation levels of PI3K,Akt,eIF4B,and the expression of Bcl-2 and Bax proteins were verified by Western blot.The experiments were conducted under two conditions:separate culture and adherent co-culture.Results:①Cell morphology:Compared with the control group,the number of cells in the FFJZ group was significantly reduced(50%),with some cells showing volume shrinkage and irregular morphology;the cell number in the combination group was the most severely reduced(75%),with most cells shrinking in volume and many cell fragments floating in the cell culture medium.②Survival and proliferation inhibition:both the FFJZ group and the combination group significantly reduced the survival rate of K562/VCR cells,and the effect of the combination group was better than that of the single drug group(F=6.808,P<0.001).The survival rate of cells in the co-culture system was higher than that in the sep-arate culture group(F=106.968,P<0.001),and the proliferation inhibition rate was lower than that in the separate culture group(F=103.228,P<0.001).③Apoptosis regulation:in group A,compared with the control group(8.15%),the apoptosis rates in the FFJZ group(20.72%)and the combination group(38.95%)were significantly increased,with the combination group being particularly obvious(P<0.05).In group B,the apoptosis results of each group were consistent with those in group A,and the apoptosis rate of each group was lower than that in group A(F=32.67,P<0.05).4.Signal pathway regulation:in co-cultured cells,the phosphorylation levels of PI3K,Akt,eIF4B,and the expression of Bcl-2 protein were downregulated in the FFJZ group and the combination group(P<0.05),while the expression of Bax protein was upregulated(P<0.05).Conclusion:The combination of FFJZ with cytarabine can enhance the pro-apoptotic effect on AML cells.The mechanism may be related to the bone marrow microenviron-ment-mediated PI3K/Akt pathway,where FFJZ inhibits the activation of the PI3K/Akt pathway,downregulates the phosphorylation of eIF4B,upregulates the pro-apoptotic gene BAX,and downregulates the expression of the anti-apop-totic gene BCL-2,thereby accelerating the apoptosis of leukemia cells and achieving the therapeutic effect on AML.This may provide a reference for AML targeted therapy.
谢宝真;陈毅宁;廖斌
福建中医药大学附属人民医院 血液病科,福建 福州 350000福建中医药大学附属人民医院 血液病科,福建 福州 350000福建中医药大学附属人民医院 血液病科,福建 福州 350000
医药卫生
急性髓系白血病骨髓微环境PI3K/Akt通路eIF4B复方君子汤
acute myeloid leukemiabone marrow microenvironmentPI3K/Akt signaling pathwayeIF4BFufang Junzi decoction
《亚太传统医药》 2026 (6)
28-33,6
福建中医药大学校管课题(XB2025014)
评论